Clinical • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • KDR (Kinase insert domain receptor) • FLT1 (Fms-related tyrosine kinase 1) • FLT4 (Fms-related tyrosine kinase 4) • VEGFC (Vascular Endothelial Growth Factor C)
|
HER-2 positive • HER-2 negative • KDR overexpression • KDR expression • VEGFA expression • FLT1 expression • VEGFA expression + FLT1 expression + KDR expression
|
Herceptin (trastuzumab) • trastuzumab biosimilar